Lewis, E.; Fine, N.; McCulloch, S.; Tay, J.; Duggan, P.; Neri, P.; Bahlis, N.; Jimenez-Zepeda, V.H.
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary. Curr. Oncol. 2024, 31, 5608-5616.
https://doi.org/10.3390/curroncol31090415
AMA Style
Lewis E, Fine N, McCulloch S, Tay J, Duggan P, Neri P, Bahlis N, Jimenez-Zepeda VH.
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary. Current Oncology. 2024; 31(9):5608-5616.
https://doi.org/10.3390/curroncol31090415
Chicago/Turabian Style
Lewis, Ellen, Nowell Fine, Sylvia McCulloch, Jason Tay, Peter Duggan, Paola Neri, Nizar Bahlis, and Victor H. Jimenez-Zepeda.
2024. "Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary" Current Oncology 31, no. 9: 5608-5616.
https://doi.org/10.3390/curroncol31090415
APA Style
Lewis, E., Fine, N., McCulloch, S., Tay, J., Duggan, P., Neri, P., Bahlis, N., & Jimenez-Zepeda, V. H.
(2024). Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary. Current Oncology, 31(9), 5608-5616.
https://doi.org/10.3390/curroncol31090415
